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Background: At present, the design of an ideal placebo control in acupuncture studies challenges researchers.
Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of
acupuncture cannot be accurately examined in clinical trials primarily because of interferences from the placebo effects.
Method: Guided by evidence-based medicine (EBM) theories, we have made an initial attempt to establish a set of
control methods for use in acupuncture studies, which is named the target disease-guided placebo-controlled (TIGER)
design. In a trial using the TIGER design, participants suffering simultaneously from a predefined target disease and a
pseudo target disease will be recruited and randomized to receive identical acupuncture intervention measures. As a
result, the interventions not only appear the same but also produce the same stimulations in both groups. The patients
in the treatment group will be informed of the actual target disease that the treatment aims for, whereas patients in the
control group will be informed that the treatment is for the pseudotarget disease. It is speculated that no psychological
response will be aroused in the control group. During data analysis, changes in the outcome measures of the patients in
the control groupreveal the real therapeutic effect of acupuncture, and those of patients in the treatment group show
both the real and placebo acupuncture effect. In this article, we explain how to put this design into use in a planned
randomized clinical trial of acupuncture for the treatment of migraine.
Results: This approach can eliminate the acupuncture placebo effect in the control group that may confound trial
results. It is possible to observe the specific and placebo effects of acupuncture for the target disease separately using
the TIGER design.
Conclusions: The proposed TIGER design has limitations. It is designed for clinical studies focusing on the specific effects
of acupuncture, and it needs to be tested and verified for practicality and feasibility in various clinical research settings.
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Acupuncture has been used in China and other coun-
tries in East Asia for a very long time, and literature has
documented its efficacy for many conditions and diseases.
Following the introduction of evidence-based medicine
(EBM) over the last decade, and amidst the growing
awareness that the randomized controlled trial (RCT) is
the gold standard for efficacy and safety assessment, there* Correspondence: shanghongcai@126.com
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reproduction in any medium, provided the orhas been heated debate about the scientificity of the previ-
ously acclaimed effectiveness of acupuncture therapy. The
first clinical trial with acupuncture was published in 1959
[1] and since then a number of studies followed. The trials
with acupuncture tried to confirm the scientific value
following the strict modern medicine merit. This trend
has been further emphasized by the EBM approach. By
September 2013, a search on the PubMed database
using the text word ‘acupuncture’ in all fields and with
the filter ‘clinical trial’ activated yielded a total of 3,326
hits. Whether the Western trial design is good for use in
eliciting the real effects of acupuncture remains theoret-
ically controversial [2]. Researchers at home and abroadLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and concluded that a design that controls the placebo ef-
fects involved in acupuncture therapy may serve as a solu-
tion. The rationale behind the placebo-controlled design
is that the global impact of a medical treatment on the hu-
man body is a combination of the real curative effect and
the placebo effects mainly caused by psychological factors
[3]. Typically, trials with a two-arm placebo-controlled de-
sign seek to elicit the same psychological effects in both
groups using blinding techniques, and the real effect of
treatment can be identified by comparing the final results
of the two groups. This design applies well to trials with
drugs where placebos with identical appearance and inert
ingredients are easy to produce and blinding is practical.
However, for a complex medical technique such as acu-
puncture whose effects largely depend on the acupoints
chosen and the patient’s needling sensations (the pursuit
for a clear-cut separation of the needling sensation and
the curative effects appears to many to be theoretically
contradictory [4]), the development of a scientific and rig-
orous placebo control poses a significant challenge.
It has been proposed that an ideal acupuncture pla-
cebo should be indistinguishable from true acupuncture
in the appearance and the sensations that it produces,
and be devoid of any therapeutic or psychological action
[5,6]. In the case of RCTs with acupuncture, the situ-
ation is complicated by the fact that both the real and
the sham treatment are considered to cause a strong pla-
cebo response [7], and some of the sham treatments have
been found to induce specific physiological responses
[8-10]. Furthermore, many of the currently available acu-
puncture placebo controls, such as sham acupuncture
[11], non-specific site stimulation [12], minimal acupunc-
ture [13], needling with a placebo needle [14], mock trans-
cutaneous electrical nerve stimulation (TENS) or mock
electroacupuncture [15,16], and sham laser acupuncture
[17], are far different from real acupuncture treatment
despite careful control and attempted blinding,thus caus-
ing varied needling stimulations and most likely inconsist-
ent placebo effects. In fact, a critique on the currently
used sham acupuncture highlighted that none can fulfill
the requirements set for a traditional placebo control [18].
Therefore, we propose the target disease-guided placebo-
controlled (TIGER) design for use in clinical trials with
acupuncture. The key features that distinguish the TIGER
design from conventional placebo designs is that real and
identical acupuncture treatment will be administered to
both groups of participants, thus ensuring both interven-
tions not only appear the same but also produce the same
stimulations. Secondly, and most importantly, patients
in the control group will be informed that the treatment
they receive is targeted for the pseudotarget disease, ra-
ther than the actual target disease, and thus no psycho-
logical response (placebo effects) such as expectationsof the alleviation of the target disease will be aroused.
Consequently, it is presumed that changes in the outcome
measures of the patients in the control group will reveal
the real therapeutic effect of acupuncture. In this paper,
we will explain how to put this design into use in the ac-
tual clinical trial setting with a case study.
Methods
Rationale and design
The proposed TIGER design is based on the hypothesis
that the overall therapeutic effect of acupuncture is a com-
bination of the real effect (specific effect) and the placebo
effect. The specific acupuncture effect is primarily deter-
mined by the acupoints chosen and the needling stimula-
tions provided, and the placebo effect originates from a
number of individual, context, and cultural factors [7]. Al-
though unsupported, we believe that patients’ psycho-
logical factors contribute the most to the acupuncture
placebo effects and therefore use ‘psychological factors’ as
an umbrella term.
In a trial using the TIGER design, participants suffering
simultaneously from the target disease and the pseudo-
target disease will be recruited, and randomly assigned
to two treatment groups (Figure 1). Subsequently, identical
intervention measures will be provided in the treatment
and control group, thus allowing for the same appearance
and sensations that are hard toachieve in currently used
placebo methods. However, patients in the treatment
group (arm one) will be informed that the treatment is for
the target disease, whereas the control group (arm two)
will be informed that the treatmentaims for the pseudo
target disease, thus eliciting different psychological re-
sponses (a key point for this design) in the two groups.
Therefore, distinct from the current practice of blinding
all participants of intervention allocation, in the TIGER de-
sign one group of patients will be wrongly informed of the
target disease that the treatment is for. We believe that this
method can curb the confounding psychological responses
that will otherwise be aroused in the control group.
We speculate that the results of arm one will show
both the real and placebo effect of acupuncture for the
target disease, while the results of arm twowill reveal
only the real acupuncture effect for the target disease.
Similarly, for the pseudotarget disease, the results of arm
onewill show the real acupuncture effect, while the re-
sults of arm two will demonstrate a combination of the
real and placebo effect. The actual effect size of acu-
puncture for both diseases and the respective placebo ef-
fect size can be determined through comparison.
Key techniques
Selection of target disease and pseudotarget disease
The selection of an appropriate target disease and deter-
mination of a pseudotarget disease is key to the successful
Outcome evaluation
for the target disease
Participants suffering simultaneously from a target disease and the pseudo-target disease
Arm two: informed of being 
treated for the pseudo-target 
disease
Arm one: informed of being 
treated for the target disease
Needling specific acupuncture 
points to treat the target disease
Needling specific acupuncture 
points to treat the target disease
Informed consent
Randomization 
Outcome evaluation for the pseudo-target disease
Outcome evaluation
for the target disease
Outcome evaluation for the pseudo-target disease
Data
analysis
Figure 1 The flow chart of the application of the TIGER design in an acupuncture trial.
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selected according to the aim of the study. Interventions
for the target disease, including acupoints chosen and
methods of manipulation, should be planned accordingly.
When choosing a pseudotarget disease, the intervention
aiming for the target disease shouldproduce no effects
on the pseudotarget disease, and vice versa. The clinicians
should incorporate traditional Chinese medicine (TCM)
theories with clinical experience before reaching a decision.
According to the TCM theories, the various signs and
symptoms that one patient presents can be attributed to
the same TCM pattern or a correlated set of patterns. It
is possible that there may be certain associations or links
between the target disease and the pseudotarget disease.
However, provided different psychological responses are
induced in the two groups, the utility of the TIGER de-
sign will not be affected.
Besides that, the feasibility of the study shall be of great
concern. To ensure successful progress of the study, re-
searchers should ensure that there are sufficient patients
simultaneously suffering from both diseases of interest to
yield results of statistical significance.
Rigorous management of research staff
To ensure the quality of clinical trials, all participating
researchers should be responsible for a specific part ofthe study. Trial designers, clinical investigators, clinicians,
patients, assessors, and statisticians should be independent
of each other. The trial designer is responsible for devising
a rigorous, scientific, and feasible protocol of the study.
Clinical investigators are in charge of patient recruitment,
randomization, treatment allocation, and communications
with the patients regarding what medication to take and
how. Clinicians should administer treatment to patients
according to the study protocol, and should not be in-
volved in outcome evaluation. Clinical assessors evaluate
patients’ outcomes, and the statisticians are responsible
for data analysis.
Selection of sensitive outcome measures
The selection of outcomes for clinical evaluation of effi-
cacy or safety should be based on the characteristics of the
target disease and the pseudotarget disease. They should
possess a certain degree of sensitivity and specificity.
An example
We plan to run a clinical study of acupuncture therapy tar-
geting migraine headaches, with constipation as the pseu-
dotarget disease. Specifically, participants suffering from
migraine and constipation at the same time will be included
and randomly assigned to arm one or arm two. Patients in
arm one will be informed that they will receive acupuncture
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they will receive acupuncture for constipation. Acupunctur-
ists who have been practicing for over 10 years will admin-
ister the following needling therapy to all participants.
Acupoints for migraine headaches chosen by literature
search and expert experienceare: Touwei (ST8), Shuaigu
(GB8), Yifeng (SJ17), Fengchi (GB20), and Temple (HN5).
Needles will be inserted into the above points and will be
manipulated using the neutral reinforcing-reducing tech-
nique of evenly distributing twirling-rotating and lifting-
thrusting of the needle, and will be retained for 30 minutes
after the ‘Deqi’ response is elicited. The treatment will be
provided once a day for 3 consecutive days.
Upon completion of the treatment, an independent as-
sessor will evaluate the outcome measures and determine
whether the same therapy produces different effects in the
two arms of participants.
The rationale underlying the TIGER designis that the
results of arm one will show both the real acupuncture ef-
fects and the placebo effects, while the results of arm two
will show only the real acupuncture effects (Table 1).Results and discussion
Using the proposed TIGER design, it is possible to ob-
serve the specific and placebo effects of acupuncture for
migraine and constipation, respectively. However, find-
ings from the assessment of outcomes of arm two are
the focus of this study.
While the effects of acupuncture therapy are more or
less influenced by patients’ perceptions of needle insertions,
we believe that guiding patients’ psychological responses
(which has been depicted as a major source of the placebo
effects) to a pseudotarget disease using this method may
help to reveal the real effects of needling for the target
disease.Advantages
Identical interventions
The same treatment will be given to the two groups of
patients (inserting needles into the same acupoints with
identical manipulations untilthe same type of ‘Deqi’ re-
sponse is provoked), thus dispelling confounding doubts
from the participantsabout the authenticity of the treat-
ment (that is, whether they received the real treatment)
and from varied perceptions of the needling stimulations.Table 1 Evaluation of the intervention effects in an acupunct
Target disease Arm one
Migraine Real acupuncture effects plus placeb
Constipation (pseudo) Real acupuncture effectc
abcdRepresent the effective rate of the four analytical units. TIGER, target disease-guBlinding
Acupuncturists will be perfectly blinded as the treatment
given to the two arms will be identical. Moreover, patients
in arm two will be blinded of the real target disease.
Ethical issues
In clinical medicine, the use of placebo treatment for pa-
tients has been subject to controversy for years. With the
help of the TIGER design, both groups of patients can re-
ceive actual acupuncture treatment and their rights will be
safeguarded.
Limitations
There are three main limitations to the TIGER design: 1)
the new control design needs to be tested for feasibility
in clinical trials for a variety of conditions and diseases.
We believe the design can be improved, and the best way
is to adapt it in practice; 2) the use of this control design
requires the patients to have both the target disease and
the pseudotarget disease at the same time. Apart from
that, interventions for the target disease should have no
therapeutic effects on the pseudotarget disease. Therefore,
recruiting qualified patients will be challenging; and 3) the
external validity of trial results is invariably affected as
participants included are highly selective. In other words,
research findings from patients suffering from a combin-
ation of conditions may not be applicable to the general
patient population. Thereforeresults must be interpreted
cautiously.
Conclusions
Acupuncture therapy has been practiced in China for
thousands of years, it has stood the test of time, and it is
widely acclaimed for its efficacy and safety. Until recently,
the evaluation of acupuncture in a scientific trial design
has been a highpriority in the cause of TCM moder-
nization. Skeptical about the therapeutic effects of acu-
puncture, some have asserted that acupuncture effects are
no more than placebo effects. To examine the net specific
effects of needling and the placebo effects separately has
challenged scholars interested in acupuncture research for
decades. In response to this challenge, we developed the
TIGER design.
It is worth noting that every type of acupuncture pla-
cebo has its own limitations. Whether it is appropriate
for use in a specific context largely depends on the aimure trial using the TIGER design
Arm two
o effectsa Real acupuncture effectsb
Real acupuncture effects plus placebo effectsd
ided placebo-controlled.
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to studies focusing on the specific effects of acupuncture,
devoid of non-specific placebo effects.
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